scholarly journals Validación del instrumento: conocimientos, creencias y aceptación de la vacuna del virus del papiloma humano

2022 ◽  
Vol 21 (1) ◽  
pp. 328-350
Author(s):  
Gabriela Iveth Martínez Figueroa ◽  
Vianet Nava Navarro ◽  
Francisco Javier Báez Hernández ◽  
Jorge Alberto Mayo Abarca ◽  
Miguel Angel Zenteno López

Introduction: The human papilloma virus (HPV) is the leading cause of cervical cancer. Having an instrument that measures the acceptance of the HPV vaccine, as well as the factors involved in the acceptance process, is an urgent need for HPV prevention. The objective was to validate the knowledge, beliefs, and acceptance of the human papillomavirus vaccine instrument.Materials and Methods: The validation process was carried out through a descriptive, cross-sectional study and a two-phase process. The population consisted of 393 mothers of girls between the ages of 9 and 11 years, belonging to the State of Puebla, with a non-probabilistic sampling for convenience; the sample was considered at a ratio of 10: 1.Results: A valid and reliable instrument was obtained with a Cronbach's Alpha of .70, a value of p <.000 for Bartlett’s sphericity test, and .82 for the KMO test. In this sense, the factor analysis resulted in a total of 40 items divided into six dimensions.Discussion: The methodological process allowed to have an empirical indicator adapted and validated for the Mexican context, since it is the only one within the context that measures the factors related to the acceptance of the HPV vaccine.Conclusion: We conclude that having an empirical indicator adapted to the Spanish language, which measures acceptance and related factors, is a contribution of great importance to society and an advance in nursing science. Introducción: El virus del papiloma humano es la primera causa de cáncer cervicouterino, contar con un instrumento que mida la aceptación de la vacuna del VPH, así como los factores que intervienen, es una necesidad para la prevención del VPH. El objetivo fue realizar la validación del instrumento conocimientos, creencias y aceptación de la vacuna del virus del papiloma humano.Materiales y Métodos: El proceso de validación se realizó a traves de un estudio descriptivo, transversal y de proceso de dos fases. La población fue de 393 madres de niñas de 9 a 11 años, pertenecientes al Estado de Puebla, con un muestreo no probabilístico por conveniencia, la muestra se consideró por razón de 10:1.Resultados: Se obtuvo un instrumento válido y confiable con un coeficiente de Alfa de Cronbach de .70, un valor de p<.000 para la prueba de esfericidad de Bartlett y la prueba de Kaiser-Meyer Olkin obtuvo un resultado de .82, en este sentido el análisis factorial dio como resultado un total de 40 ítems divididos en seis dimensiones.Discusión: El proceso metodológico permitió contar con un indicador empírico adaptado y valido al contexto mexicano, debido a que es el único dentro del contexto que mide los factores relacionados con la aceptación de la vacuna del virus del papiloma humano.Conclusión: Se concluye que tener un indicador empírico adaptado al idioma español, que mida la aceptación y los factores relacionados, es un aporte de gran importancia para la sociedad y un avance para la ciencia en enfermería.

2016 ◽  
Vol 20 (2) ◽  
pp. 131-134 ◽  
Author(s):  
Velia Leybas Nuño ◽  
Marisa Gonzalez ◽  
Salena Meyer Loredo ◽  
Brittany M. Nigon ◽  
Francisco Garcia

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Hossein Pakdaman ◽  
Ali Amini Harandi ◽  
Koroush Gharagozli ◽  
Farshid Alaeddini ◽  
Akram Esfandani ◽  
...  

AbstractEpilepsy has garnered increased public health focus because patients who suffer from epilepsy experience pronounced and persistent health and socioeconomic disparities despite treatment and care advances. The epidemiology of epilepsy is diverse in different countries and regions. This nationwide population-based cross-sectional study was conducted to determine the life time prevalence and health related factors of epilepsy for the first time in Iran through a two-phase door-to-door survey method. In phase I, a screening for epilepsy was performed on 68,035 people. Then in phase II, after the neurological evaluation of participants and reviewing medical records, 1130 subjects with epilepsy was confirmed. The life time prevalence of epilepsy was achieved to be 16.6 per 1000 people (95% CI 15.4–17.8) with the average age onset 19.1 ± 21.1 (active prevalence 9.5 per 1000 people). Focal seizure (59.3%), generalized epilepsy (38%) and unknown types of epilepsy (2.7%) were detected among participants. The overall life time prevalence of febrile convulsion was 4.1 per 1000 people. The frequency of attacks per year and per month were 3.0 ± 1.6 and 0.5 ± 0.1, respectively. Age-specific life time prevalence was highest among the age group of 15–19 years old [32.7 per 1000 persons (95% CI 29.1–36.8)] and it was higher in male (53.8%) than female (46.2%) participants. Our results showed that the life time prevalence of epilepsy in Iran is higher than worldwide average.


JMIR Cancer ◽  
10.2196/13832 ◽  
2019 ◽  
Vol 5 (2) ◽  
pp. e13832 ◽  
Author(s):  
Jennifer Cunningham-Erves ◽  
Tatsuki Koyama ◽  
Yi Huang ◽  
Jessica Jones ◽  
Consuelo H Wilkins ◽  
...  

BMJ Open ◽  
2019 ◽  
Vol 9 (9) ◽  
pp. e024291
Author(s):  
Ali Taghizadieh ◽  
Saber Azami-Aghdash ◽  
Reza Piri ◽  
Mohammad Naghavi-Behzad ◽  
Hossein Jabbari Beyrami

ObjectiveDischarge against medical advice (DAMA) is a critical problem in hospitals and has several consequences for healthcare systems. The aim of this study was to determine and compare the rate of DAMA and its related factors before and after executing the healthcare transformation plan (HTP) in Iran.MethodsIn a two-phase, cross-sectional study, the DAMA information of 200 patients in 2016 (after HTP) and the patients of a previous study in 2012 (before HTP) was compared. Samples were randomly selected from the main referral centre in the north-west of Iran. Data were collected using a validated and reliable questionnaire and analysed using the SPSS V.16 software.ResultsIn the post-HTP plan period, the rate of DAMA was 3.9%, while this rate was 5.49% in 2012 (p=0.029). A total of 15% (108 out of 721) of patients in the postreform group and 13.5% (101 out of 747) in the prereform group were rehospitalised (p=0.411). The three main categories of reasons for DAMA in 2012 and 2016 were as follows: patient-related factors, 27% vs 45%; staff-related factors, 33% vs 30%; and hospital-related factors (basic amenities), 40% vs 25%. In both periods, the average scores of patient satisfaction were almost the same; however, satisfaction regarding environmental and human factors in hospitals had changed significantly after HTP (p<0.05).ConclusionsThere was a decrease in the rate of DAMA after HTP in Iran. Considering DAMA as a multifactorial phenomenon, this might be due to the higher relative satisfaction after HTP, indicating an increase in public confidence in general hospitals.


2019 ◽  
Vol 16 (5) ◽  
pp. 1018-1023 ◽  
Author(s):  
Tiffany D. Pomares ◽  
Alison M. Buttenheim ◽  
Avnika B. Amin ◽  
Caroline M. Joyce ◽  
Rachael M. Porter ◽  
...  

2017 ◽  
Vol 4 (suppl_1) ◽  
pp. S325-S325
Author(s):  
Tomohiro Katsuta ◽  
Charlotte Moser ◽  
Paul Offit ◽  
Kristen Feemster

Abstract Background Current vaccination coverage of Human Papillomavirus vaccine (HPVV) in Japan is less than 1% because the Ministry of Health, Labour and Welfare (MHLW) suspended its proactive recommendations for HPVV in 2013 after some reports of possible adverse events following immunization. We evaluated the perception of Japanese physicians about HPVV in order to consider the appropriate countermeasure to improve HPVV coverage in Japan. Methods We conducted a cross-sectional study using a postal questionnaire targeting 330 Japanese physicians (78 pediatricians, 225 internists and 27 obstetricians-gynecologists (OB-GYNs)) in Kawasaki, Japan in 2016. The questionnaire comprised questions about education frequency, physicians’ perception and recommendation behavior related to adolescent vaccines (HPVV, diphtheria tetanus toxoid (DT) and inactivated influenza vaccine (IIV)). Results Valid responses were obtained from 148 (44.9%) physicians (pediatricians 80.8%, internists 31.6% and OB-GYNs 51.9%). Very few (8.0%) of physicians provided HPVV during the past month. Only 21.3% of physicians educated aggressively about HPVV, which was significantly less frequently than DT (61.7%) and IIV (88.6%). Similarly, 53.1% of physicians recommended HPVV aggressively, which was significantly less frequently than DT (83.1%) and IIV (80.3%). We found no significant differences in the frequency of HPVV education or recommendation by pediatricians, internists and OB/GYNs (22.4% vs. 16.9% vs. 35.7% and 54.8% vs. 47.9% vs. 71.5%, respectively). However, 90.0% of physicians answered that if MHLW were to reinstate its HPVV recommendation, they would more aggressively recommend HPVV for adolescents. Conclusion Although Japanese physicians were cautious about HPVV and infrequently provided education or made a recommendation for HPVV compared with other adolescent vaccines, our survey suggested such a passive attitude could be improved by the MHLW resuming its proactive recommendation in Japan. Disclosures All authors: No reported disclosures.


2021 ◽  
Author(s):  
Eshetu Yisihak ◽  
Feleke Gebremeskel ◽  
Samuel Abebe ◽  
Desta Markos ◽  
Gebresilasea Gendisha

Abstract Introduction: Cervical cancer is the second leading cause of cancer-related mortality among females in Ethiopia. The knowledge regarding human papillomavirus vaccination and its acceptability among adolescent girls affects the human papillomavirus vaccine uptake, however, the status of knowledge of the human papillomavirus vaccination among adolescent girls in Ethiopia, particularly in this study area is not well known. Therefore, this study aimed to determine the knowledge of human papillomavirus vaccination and associated factors among primary school girls in Arba Minch town, South Ethiopia, 2020. Methods: A school-based cross-sectional study in which 516 school girls participated was conducted on January 24, 2020. The study participants were selected by a simple random sampling technique. A pre-tested and self-administered questionnaire was used to collect the data. Data was entered to Epi_data version 4.6 and exported to SPSS Version 23 for analysis. The logistic regression model was used to identify the statistically significant variables for knowledge of the human papillomavirus vaccination. Results: The overall knowledge level of the study participants in this study was 71.7%. Their main information source was social media 41.74% followed by health care workers 29.69%. Conclusions: Nearly three-fourths of the study participants were knowledgeable about human papillomavirus vaccination. The knowledge about the human papillomavirus vaccination shows a positive association with age, education level, access to information sources, and parents' educational status. Keywords: Arbaminch town; cervical cancer; Ethiopia; human papillomavirus vaccine; girls; knowledge; schools


Sign in / Sign up

Export Citation Format

Share Document